Amyloid-Inspired Synergistic Short Peptide Scaffold against Mitochondrial Dyshomeostasis in Traumatic Brain Injury

Traumatic Brain Injury (TBI) initiates Ca 2+ dysregulation, which intensifies mitochondrial oxidative stress, thereby promoting the advancement of secondary neurotoxicity. Studies suggest that, unlike previous understanding of global intracellular Ca 2+ overload, localized Ca 2+ microdomains in connection with mitochondrial dysfunction cause the primary toxicity in TBI. This highlights the need for strategies that modulate Ca 2+ signaling with spatial precision. In this study, we report a supramolecular binary peptide system, comprising coassembled RDI and NDI sequences, designed to disrupt pathological Ca 2+ -reactive oxygen species (ROS) coupling. This coassembled scaffold (1:1 molar stoichiometric ratio) integrates arginine-mediated electrostatic localization with low-affinity, aspartate-based Ca 2+ coordination, enabling transient interaction with Ca 2+ microdomains near mitochondrial interfaces. In in vitro conditions of TBI-mimetic injury, the peptide mix selectively reduces mitochondrial Ca 2+ uptake, leading to a marked suppression of mitochondrial ROS generation. This modulation of Ca 2+ microdomains stabilizes mitochondrial membrane potential, limits oxidative damage, and improves neuronal viability under excitotoxic stress. MitoSOX assessment showed that the peptide mix evidently suppresses mitochondrial superoxide generation under TBI-mimetic excitotoxic conditions. Peptide treatment stabilizes mitochondrial membrane potential and maintains homeostatic mitochondrial networks, preventing injury-induced fragmentation. In a rodent model of brain injury, administration of the peptide mix reduces peri-lesional cortex and promotes tissue recovery that could directly be associated with improved neuronal survival. Importantly, the peptides function through transient modulation of Ca 2+ microdomains rather than Ca 2+ chelation or direct antioxidant activity. These findings establish a new design paradigm for peptide materials targeting Ca 2+ driven mitochondrial pathology and suggest a promising strategy for mitigating secondary injury mechanisms in neurotrauma.